TIDMTERN
Tern PLC
02 March 2021
REACH - non-regulatory announcement
2 March 2021
Tern Plc
("Tern" or the "Company")
Portfolio News
Tern Plc (AIM:TERN), the investment company specialising in the
Internet of Things ("IoT"), is pleased to provide an update on the
recent activities of a number of its portfolio companies), being
Device Authority Limited ("Device Authority"), Talking Medicines
Limited ("Talking Medicines") and Wyld Networks Limited ("Wyld
Networks"):
-- Device Authority successfully concluded its two day, sponsor
funded, 'Virtual IoT Security Summit' last week, with expert
speakers and strategic partners from some of the largest global
players in the cyber identity and access management ("IAM") sector.
The event attracted over 2,000 registrants, with over 1,400
delegates attending live topical sessions on solving the complex
issues of IoT security. Support was received from Device
Authority's strategic partners and industry leaders including
Microsoft, BSI, EPS Global, Entrust, Ordr, Venafi and Imagination
Technologies. The various presentations from the webinar can be
viewed on-demand at:
https://www.brighttalk.com/summit/4892-virtual-iot-security-summit/
-- Talking Medicines has been named on Healthcare UK's "First
100" list, published by the Department of International Trade,
recognising the UK's leading digital health innovators.
-- Wyld Networks has entered into a partnership with Fujitsu
through the Fujitsu Ecosystem Platform to provide a further route
to market for its products.
Commenting Al Sisto, CEO of Tern, said :
"I am pleased to see that the recent momentum with our portfolio
companies is continuing. All have had a good start to 2021 and have
promising pipelines of business.
"Device Authority's IoT summit last week, funded by its partner
sponsors, was a particular milestone for the company, demonstrating
the depth of their relationships and the important position their
KeyScaler product has in the IoT. I wholly endorse one speaker from
a global software company who commented that KeyScaler is 'the glue
that holds the IoT together'.
"I would also like to congratulate Talking Medicines on being
selected as part of Healthcare UK's 'Fast 100'. This recognises
Talking Medicines' innovation and their commitment to global
expansion.
"I look forward to providing further regular updates on the
progress of our portfolio companies in due course."
Further information on Talking Medicines and the First 100
Talking Medicines has been named on Heathcare UK's "First 100"
list published by the Department for International Trade. The
"First 100" companies were selected after a rigorous process based
on criteria including how committed they were to export and
international expansion, the global uniqueness of their innovation,
their track-record of working collaboratively with Healthcare UK,
their responsiveness, and how well they represent the UK journey
and direction in digital health, particularly with the NHS. The
Department for International Trade have stated the list will be
updated twice a year.
The First 100 campaign is backed by Healthcare UK, European
Connected Health Alliance (ECHA), Association of British HealthTech
Industries (ABHI), Scottish Development International, Innovate UK,
HIMSS and the National Association of Primary Care (NAPC).
Commenting, Hassan Chaudhury, digital health specialist,
Healthcare UK, said: "The First 100 articulates the exportable
strengths that the UK has in health tech and showcases those that
stand out for being tried and tested and most importantly, making a
difference across one of the most complex health systems in the
world, during its most challenging time."
Enquiries
Tern Plc via IFC Advisory
Al Sisto (CEO)
Sarah Payne (CFO)
Allenby Capital Limited Tel: 0203 328 5656
(Nominated Adviser and Broker)
David Worlidge / Alex Brearley (Corporate
Finance)
Matt Butlin / Kelly Gardiner (Sales
and Corporate Broking)
IFC Advisory Tel: 0203 934 6630
(Financial PR and IR) tern@investor-focus.co.uk
Tim Metcalfe
Graham Herring
Florence Chandler
About Reach announcements
This is a Reach announcement. Reach is an investor communication
service aimed at assisting listed and unlisted (including AIM
quoted) companies to distribute media only / non-regulatory news
releases into the public domain. Information required to be
notified under the AIM Rules for Companies, Market Abuse Regulation
or other regulation would be disseminated as an RNS regulatory
announcement and not on Reach.
This information is provided by Reach, the non-regulatory press
release distribution service of RNS, part of the London Stock
Exchange. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
Reach is a non-regulatory news service. By using this service an
issuer is confirming that the information contained within this
announcement is of a non-regulatory nature. Reach announcements are
identified with an orange label and the word "Reach" in the source
column of the News Explorer pages of London Stock Exchange's
website so that they are distinguished from the RNS UK regulatory
service. Other vendors subscribing for Reach press releases may use
a different method to distinguish Reach announcements from UK
regulatory news.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NRADKDBPCBKDKNK
(END) Dow Jones Newswires
March 02, 2021 02:00 ET (07:00 GMT)
Tern (LSE:TERN)
Historical Stock Chart
From Apr 2024 to May 2024
Tern (LSE:TERN)
Historical Stock Chart
From May 2023 to May 2024